Foyston, Gordon, & Payne Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$6.27M |
| 2 |
UNVR
Univar Solutions Inc.
UNVR
|
+$5.97M |
| 3 |
Philip Morris
PM
|
+$4.42M |
| 4 |
VMW
VMware, Inc
VMW
|
+$4.36M |
| 5 |
Becton Dickinson
BDX
|
+$4.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$23.4M |
| 2 |
C.H. Robinson
CHRW
|
+$8.43M |
| 3 |
Motorola Solutions
MSI
|
+$7.43M |
| 4 |
Baxter International
BAX
|
+$6.02M |
| 5 |
Keysight
KEYS
|
+$4.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.51% |
| 2 | Healthcare | 20.14% |
| 3 | Financials | 16.3% |
| 4 | Industrials | 12.24% |
| 5 | Consumer Staples | 11.64% |
Similar funds
Foyston, Gordon, & Payne's Q4 2022 Portfolio in Review
As of Q4 2022, Foyston, Gordon, & Payne held 70 positions worth $362M, down 0.81% from $365M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Foyston, Gordon, & Payne withdrew a net $38.5M in Q4 2022, closing 9 positions and reducing 24 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $23.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Foyston, Gordon, & Payne opened a new position in Fiserv Inc worth $6.36M.
- Foyston, Gordon, & Payne's largest Q4 2022 buy was Fiserv Inc: 62,974 shares worth $6.36M.
- Foyston, Gordon, & Payne added most to Philip Morris in Q4 2022, an estimated $4.42M increase.
- Foyston, Gordon, & Payne's biggest Q4 2022 reduction was Motorola Solutions, cutting an estimated $7.43M.
- Foyston, Gordon, & Payne fully exited iShares MSCI Emerging Markets ETF in Q4 2022, selling an estimated $23.4M.
- Foyston, Gordon, & Payne's ten largest holdings make up 39% of its $362M portfolio in Q4 2022.
- Foyston, Gordon, & Payne opened 8 new positions and closed 9 in Q4 2022.
- Foyston, Gordon, & Payne's portfolio value fell 0.81% quarter-over-quarter to $362M.
Based on Foyston, Gordon, & Payne's 13F filing for Q4 2022, filed 9 Feb 2023.